FDA Staffers Oppose Proposed Clearance of Peptides for Compounding Pharmacies

FDA Staffers Oppose Proposed Clearance Of Peptides

FDA Staffers Oppose Proposed Clearance Of Peptides Authored by Zachary Stieber via The Epoch Times, Food and Drug Administration staffers said in newly released documents that they do not support letting compound pharmacies manufacture seven popular peptides. The Food and Drug Administration in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times FDA personnel said in documents posted online on June 29 that there are safety concerns with the peptides, including t...

By Tyler Durden